Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries

Carcinogenesis

Volumn 18, Issue 7, 1997, Pages 1355-1358

  Watanabe, Masatoshi ^a   Fukutome, Kazuo ^a   Shiraishi, Taizo ^a   Murata, Mariko ^a   Kawamura, Jyuichi ^a   Shimazaki, Jun ^b   Kotake, Toshihiko ^c   Yatani, Ryuichi ^a  

^a MIE UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CENTER FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; EUROPE; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UNITED STATES;

AGED; AGED, 80 AND OVER; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0031431667     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.7.1355     Document Type: Article

References (43)

1. Levine, A.J., Perry, M.E., Chang, A., Silver, A., Dittmer, D., Wu, M. and Welsh, D. (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumor-suppressor gene in tumorigenesis. Br. J. Cancer, 69, 409-416.
2. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
3. Jones, P.A., Buckley, J.D., Henderson, B.E., Ross, R.K. and Pike, M.C. (1991) From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res., 51, 3617-3620.
4. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
5. Nakasawa, H., English, D., Randell, P., Nakazawa, K., Martel, N., Armstrong, B.K. and Yamasaki, H. (1994) Specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. Natl Acad. Sci. USA, 91, 360-364.
6. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G to T mutations of the p53 gene in hepatocellular carcinomas from southern Africa. Nature, 350, 429-432.
7. Hsu, I.C., Metacalf, R.A., Sun, T., Welsh, J.A., Wang, N.J. and Harris, C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature, 350, 427-428.
8. Gittes, R.F. (1991) Carcinoma of the prostate. N. Engl. J. Med., 324, 236-245.
9. Waterhouse, J., Muir, C., Shanmugaratnam, K. and Powell, J. (eds) (1982) Cancer Incidence in Five Continents, vol. 4. IARC Scientific Publication, Lyons, France, p. 746.
10. Statistics and Information Department, Ministry of Health and Welfare (1993) Vital Statistics 1991 Japan, Health and Welfare Statistics Association, Tokyo, pp. 266-271.
11. Yatani, R., Shiraishi, T., Nakakuki, K., Kusano, I., Takanari, H., Hayashi, T. and Stemmermann, G.N. (1988) Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 and 1982-1986. J. Natl Cancer Inst., 80, 683-687.
12. Watanabe, M., Shiraishi, T., Yatani, R., Nomura, A.M.Y. and Stemmermann, G.N. (1994) International comparison on ras gene mutations in latent prostate carcinoma. Int. J. Cancer, 58, 174-178.
13. Carter, B.S., Carter, H.B. and Issacs, W.B. (1990) Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate, 16, 187-197.
14. Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G.N., Welsh, R.A. and Correa, P. (1982) Geographic pathology of latent prostatic carcinoma. Int. J. Cancer. 29, 611-616.
15. Watanabe, M., Ushijima, J., Kakiuchi, H., Shiraishi, T., Yatani, R., Shimazaki, U., Kotake, J., Sugimura, T. and Nagao, M. (1994) p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and Western countries. Jpn J. Cancer Res., 85, 904-910.
16. Japanese Urological Association and The Japanese Pathological Society (1992) The General Rules for Clinical and Pathological Studies on Prostatic Cancer, 2nd edn. Kanehara Press, Tokyo, pp. 40-46.
17. Gleason, D.F. and Mellinger, T.G. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J. Urol., 111, 58-64.
18. Navone, N.M., Troncoso, P., Pisters, L.L., Goodrow, T.L., Palmer, J.L., Nichols, W.W., von Eschenbach, A.C. and Conti, C.J. (1993) p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J. Natl Cancer Inst., 85, 1657-1669.
19. Bookstein, R., MacGrogan, D., Hilsenbeck, S.G., Sharkey, F. and Allred, D.C. (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res., 53, 3369-3373.
20. Nigro, J.M., Baker, S.J., Preisinger, A.C. et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
21. Imaly, J.A. and Linn, S. (1988) DNA damage and oxygen radical toxicity. Science, 240, 1302-1309.
22. Puisieux, A., Lim, S., Groopman, J. and Ozturk, M. (1991) Selecting targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51, 6185-6189.
23. Foster, P.L., Eisenstadt, E. and Miller, J.H. (1983) Base substitution mutations induced by metabolically activated aflatoxin B1. Proc. Natl Acad. Sci. USA, 80, 2695-2698.
24. Uchida, T., Wada, C,. Shitara, T., Egawa, S. and Koshiba, K. (1993) Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer. Br. J. Cancer, 68, 751-755.
25. Konishi, N., Hiasa, Y., Hayashi, I. et al. (1995) p53 mutations occur in clinical, but not latent, human prostate carcinoma. Jpn J. Cancer Res., 86, 57-63.
26. Kubota, Y., Shuin, T., Uemura, H. et al. (1995) Tumor suppressor gene p53 mutations in human prostate cancer. Prostate, 27, 18-24.
27. Suzuki, H., Komiya, A., Aida, S., Ito, H., Yatani, R. and Shimazaki, J. (1996) Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate, 28, 318-324.
28. Effert, P.J., McCoy, R.H., Walther, P.J. and Liu, E.T. (1993) p53 gene alterations in human prostate carcinoma. J. Urol., 150, 257-261.
29. Chi, S.-G,. deVere White, R.W., Meyers, F.J., Siders, D.B., Lee, F. and Gumerlock, P.H. (1994) p53 in prostate cancer: frequently expressed transition mutations. J. Natl Cancer Inst., 86, 926-933.
30. Voeller, H.J., Sugars, L.Y., Pretlow, T. and Gelman, E. (1994) p53 oncogene mutations in human prostate cancer specimens. J. Urol., 151, 429-495.
31. Dinjens, W.N.M., Van Der Weiden, M.M., Schroeder, F.H., Bosman, F.T. and Trapman, J. (1994) Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int. J. Cancer, 56, 630-633.
32. Moyret-Lalle, C., Marçis, C., Jacquemier, J., Moles, J.-J., Daver, A., Soret, J.-Y., Jeanteur, P., Ozturk, M. and Theillet, C. (1995) ras, p53 and HPV status in benign and malignant prostate tumors. Int. J. Cancer, 64, 124-129.
33. Berner, A., Geitvik, G., Karlsen, F., Fosså, S., Nesland, J.M. and Børresen, A.-L. (1995) TP53 mutations in prostate cancer. Analysis of pre-and post-treatment archival formalin-fixed tumour tissue. J. Pathol., 176, 299-308.
34. Wink, D.A., Kasprzak, K.S., Maragos, C.M. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
35. Cooper, D.N. and Krawczak, M. (1989) Cytosine methylation and the fate of CpC dinucleotides in vertebrate genomes. Hum. Genet., 83, 181-188.
36. Kasai, H. and Nishimura, S. (1986) Hydroxylation of guanine in nucleotides and DNA at the c-8 position by heated glucose and oxygen radical forming agents. Environ. Health Perspect., 67, 111-116.
37. Baker, S.J., Preisinger, A.C., Jessup, J.M., Paraskeva, C., Markowitz, S., Willson, J.K.V., Hamilton, S. and Vogelstein, B. (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722.
38. Cariello, N.F., Piegorsch, W.W., Adams, W.T. and Skopek, T.R. (1994) Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis, 15, 2281-2285.
39. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y. and Ueda, R. (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52, 734-736.
40. Chiba, I., Takahashi, T., Nau, M.M. et al. (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5, 1603-1610.
41. Somers, K.D., Merrick, M.A., Lopez, M.E., Incognito, L.S., Schechter, G.L. and Casey, G. (1992) Frequent p53 mutations in head and neck cancer. Cancer Res., 52, 5997-6000.
42. Ruggeri, B., DiRado, M., Zhang, S.Y., Bauer, B., Goodrow, T. and Klein-Szanto, A.J.P. (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl Acad. Sci. USA, 90, 1013-1017.
43. Biggs, P., Warren, W., Venitt, S. and Stratton, M.R. (1993) Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis, 8, 275-283.